Is Ocular Therapeutix Inc’s (NASDAQ: OCUL) Stock Ready For A Price Spike?

In the last trading session, 9.12 million shares of the Ocular Therapeutix Inc (NASDAQ:OCUL) were traded, and its beta was 1.43. Most recently the company’s share price was $5.22, and it changed around -$0.64 or -10.92% from the last close, which brings the market valuation of the company to $775.85M. OCUL currently trades at a discount to its 52-week high of $11.31, offering almost -116.67% off that amount. The share price’s 52-week low was $2.00, which indicates that the current value has risen by an impressive 61.69% since then. We note from Ocular Therapeutix Inc’s average daily trading volume that its 3-month average coming to 2.15 million.

Ocular Therapeutix Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.38. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended OCUL as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Ocular Therapeutix Inc is expected to report earnings per share of $Ocular Therapeutix, Inc. for the current quarter.

Ocular Therapeutix Inc (NASDAQ:OCUL) trade information

Instantly OCUL has showed a red trend with a performance of -10.92% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 17.04% year-to-date, but still down -34.67% over the last five days. On the other hand, Ocular Therapeutix Inc (NASDAQ:OCUL) is -47.27% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $17, which translates to bulls needing to increase their stock price by 69.29% from its current value. Analyst projections state that OCUL is forecast to be at a low of $10 and a high of $24.

Ocular Therapeutix Inc (OCUL) estimates and forecasts

Ocular Therapeutix Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 119.79 percent over the past six months and at a 33.33% annual growth rate that is well above the industry average of 10.20%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 8.38%.